BioMedomics Company
BioMedomics, Inc. manufactures and markets bioscience products and medical devices. The company’s products includes deoxyribonucleic acid research reagents; human, mouse, and rat genepool products; tissue array products; and antibodies. It designs and develops real-time cell electronic sensing technology for analyzing cell-based assay procedures. The company offers contract assay services such as cell proliferation, cytotoxicity, adhesion, viability, and invasion. Additionally, it provides drug discovery, research, and development services. BioMedomics is based in Research Triangle Park, North Carolina.
Technology:
MarketPlace
Industry:
P4 Medicine
Headquarters:
Others
Founded Date:
2006-01-01
Employees Number:
1-10
Investors Number:
1
Total Funding:
$1.2M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Grant
Register and Claim Ownership